PubMed:23275522 / 0-328 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":277,"end":283},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00031MO"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T2","span":{"begin":109,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":277,"end":283},"obj":"https://glytoucan.org/Structures/Glycans/G00031MO"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":0,"end":16},"obj":"gene:5743"},{"id":"T1","span":{"begin":94,"end":107},"obj":"disease:C0678222"},{"id":"T2","span":{"begin":81,"end":89},"obj":"gene:6482"},{"id":"T3","span":{"begin":94,"end":107},"obj":"disease:C0678222"},{"id":"T4","span":{"begin":81,"end":89},"obj":"gene:6482"},{"id":"T5","span":{"begin":94,"end":107},"obj":"disease:C0006142"},{"id":"T6","span":{"begin":0,"end":16},"obj":"gene:5743"},{"id":"T7","span":{"begin":94,"end":107},"obj":"disease:C0006142"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"},{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"},{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":221,"end":234},"obj":"HP_0003002"},{"id":"T2","span":{"begin":221,"end":234},"obj":"HP_0100013"},{"id":"T3","span":{"begin":228,"end":234},"obj":"HP_0002664"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"23275522-0#0#16#gene5743","span":{"begin":0,"end":16},"obj":"gene5743"},{"id":"23275522-0#81#89#gene6482","span":{"begin":81,"end":89},"obj":"gene6482"},{"id":"23275522-0#94#107#diseaseC0006142","span":{"begin":94,"end":107},"obj":"diseaseC0006142"},{"id":"23275522-0#94#107#diseaseC0678222","span":{"begin":94,"end":107},"obj":"diseaseC0678222"},{"id":"23275522-0#94#107#diseaseC0006142","span":{"begin":94,"end":107},"obj":"diseaseC0006142"},{"id":"23275522-0#94#107#diseaseC0678222","span":{"begin":94,"end":107},"obj":"diseaseC0678222"}],"relations":[{"id":"0#16#gene574394#107#diseaseC0006142","pred":"associated_with","subj":"23275522-0#0#16#gene5743","obj":"23275522-0#94#107#diseaseC0006142"},{"id":"0#16#gene574394#107#diseaseC0678222","pred":"associated_with","subj":"23275522-0#0#16#gene5743","obj":"23275522-0#94#107#diseaseC0678222"},{"id":"0#16#gene574394#107#diseaseC0006142","pred":"associated_with","subj":"23275522-0#0#16#gene5743","obj":"23275522-0#94#107#diseaseC0006142"},{"id":"0#16#gene574394#107#diseaseC0678222","pred":"associated_with","subj":"23275522-0#0#16#gene5743","obj":"23275522-0#94#107#diseaseC0678222"},{"id":"81#89#gene648294#107#diseaseC0006142","pred":"associated_with","subj":"23275522-0#81#89#gene6482","obj":"23275522-0#94#107#diseaseC0006142"},{"id":"81#89#gene648294#107#diseaseC0678222","pred":"associated_with","subj":"23275522-0#81#89#gene6482","obj":"23275522-0#94#107#diseaseC0678222"},{"id":"81#89#gene648294#107#diseaseC0006142","pred":"associated_with","subj":"23275522-0#81#89#gene6482","obj":"23275522-0#94#107#diseaseC0006142"},{"id":"81#89#gene648294#107#diseaseC0678222","pred":"associated_with","subj":"23275522-0#81#89#gene6482","obj":"23275522-0#94#107#diseaseC0678222"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":94,"end":107},"obj":"Disease"},{"id":"T2","span":{"begin":221,"end":234},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":94,"end":107},"obj":"Phenotype"},{"id":"T2","span":{"begin":221,"end":234},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0003002"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0003002"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":277,"end":283},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00031MO"},{"id":"A5","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":94,"end":107},"obj":"Phenotype"},{"id":"T2","span":{"begin":221,"end":234},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0003002"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0003002"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":94,"end":107},"obj":"Disease"},{"id":"T2","span":{"begin":221,"end":234},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":94,"end":100},"obj":"Body_part"},{"id":"T2","span":{"begin":221,"end":227},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T2","span":{"begin":109,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T2","span":{"begin":109,"end":172},"obj":"Sentence"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":277,"end":283},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00031MO"},{"id":"A5","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T1","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T2","span":{"begin":109,"end":172},"obj":"Sentence"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":94,"end":100},"obj":"Body_part"},{"id":"T2","span":{"begin":221,"end":227},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.\nAberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the cor"}